Multicenter study on acute type A aortic dissection
Nordic Multicenter Study of Risk Factors, Surgical Treatment and Outcomes in Acute Type a Aortic Dissection
This study is trying to learn more about patients with acute type A aortic dissection by looking at their health details, surgeries, and recovery to see what affects their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Trial ID | NCT06862583 on ClinicalTrials.gov |
What this trial studies
The Nordic Consortium for Acute Type A Aortic Dissection-2 (NORCAAD-2) is a collaborative observational study involving multiple centers across the Nordic countries and the Netherlands. It aims to gather comprehensive data on patients with acute type A aortic dissection, focusing on preoperative characteristics, risk factors, surgical procedures, postoperative outcomes, and mortality rates over both short and long terms. By analyzing a large cohort of patients, the study seeks to enhance understanding of this critical vascular emergency and identify factors influencing outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with acute type A aortic dissection within 14 days of symptom onset.
Not a fit: Patients under 18 years of age will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could improve patient management and outcomes for those suffering from acute type A aortic dissection.
How similar studies have performed: Other studies focusing on multicenter data collection for acute aortic dissection have shown promise in improving understanding and treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute (within 14 days of onset) type A aortic dissection or similar acute aortic syndrome Exclusion Criteria: * Age \<18 years at onset
Where this trial is running
Stockholm
- Karolinska Institute — Stockholm, Sweden (Recruiting)
Study contacts
- Principal investigator: Christian Olsson, MD, PhD — Karolinska Institutet
- Study coordinator: Christian Olsson, MD, PhD
- Email: christian.olsson@ki.se
- Phone: +46812370000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.